Intrinsiqq
IB Acquisition Corp logo

IB Acquisition Corp Insider Trading

IBAC

Compare
Last 12 months

No open-market buying or selling by insiders.

No executive or director has bought shares on the open market in the last two years.

Net open-market
$0
0 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
0 / 0
executives and directors
Last open-market buy
None
in the last two years

Get an email when IBAC's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Mar 23No plan
    AQR Arbitrage LLC
    Large holder · sold 335,000 at avg $10.80
    $3.62M
    49% of stake
  • Mar 20No plan
    AQR Capital Management LLC
    Large holder · sold 4,619 at $10.75
    50K
    100% of stake
  • Oct 9, 2025No plan
    AQR Arbitrage LLC
    Large holder · sold 195,806 at avg $10.44
    $2.04M
    22% of stake
  • Oct 2, 2025No plan
    AQR Arbitrage LLC
    Large holder · sold 4,400 at avg $10.50
    46K
    0.5% of stake
  • Oct 1, 2025No plan
    AQR Capital Management Holdings, LLC
    Large holder · sold 29,821 at avg $10.50
    313K
    3.2% of stake
  • Sep 30, 2025No plan
    AQR Capital Management Holdings, LLC
    Large holder · sold 72,664 at avg $10.51
    764K
    7.3% of stake
  • Sep 29, 2025No plan
    AQR Capital Management Holdings, LLC
    Large holder · sold 122,309 at avg $10.50
    $1.28M
    11% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch IBAC, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Services-Commercial Physical & Biological Research · Pick stocks to compare with IBAC

CompareIntrinsic value
MXCTMaxCyte, Inc.
$1.37+7.03%16
ABSIAbsci Corporation
$7.51-7.97%10
BIAFBioAffinity Technologies Inc.
$1.65-10.81%20
OABIOmniAb, Inc.
$4.66-7.36%31
CRLCharles River Laboratories International, Inc.
$314.32-4.15%31
NRCNrc Health
$25.20+0.84%35
INCYIncyte Corporation
$114.63-1.07%43
IQVIQVIA Holdings Inc.
$245.82-1.89%62

Held by ETFs

IBAC is in 2 US ETFs. The largest of them, with IBAC's weight in each:

Spot a number that looks wrong? Check it in IBAC's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing IBAC

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.